4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, N; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Takahashi, A; Tsutsumi, K | 1 |
| Harada, N; Hattori, A; Hosaka, T; Li, Q; Lian, X; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Shimohata, T; Takahashi, A; Wu, Q; Yoshida, M | 1 |
2 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Muscle Contraction
| Article | Year |
|---|---|
NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activators; Flavonoids; Hypolipidemic Agents; In Vitro Techniques; Lipoprotein Lipase; Male; Muscle Contraction; Muscle, Smooth, Vascular; Organophosphorus Compounds; Phenylephrine; Potassium Chloride; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Staurosporine; Vasoconstriction; Vasodilation; Verapamil | 2007 |
NO-1886, a lipoprotein lipase activator, attenuates contraction of rat intestinal ring preparations.
Topics: Animals; Benzamides; Calcium; Diabetes Mellitus, Type 2; Gastrointestinal Motility; Hypolipidemic Agents; In Vitro Techniques; Intestinal Diseases; Intestines; Lipoprotein Lipase Activators; Male; Muscle Contraction; Muscle, Smooth; Myosin-Light-Chain Kinase; Obesity; Organophosphorus Compounds; Peptides; Rats; Rats, Inbred OLETF; Rats, Wistar | 2008 |